Page last updated: 2024-10-28

hydroxychloroquine and Orthopedic Disorders

hydroxychloroquine has been researched along with Orthopedic Disorders in 5 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research Excerpts

ExcerptRelevanceReference
"Childhood-onset systemic lupus erythematosus (SLE) is a severe, lifelong, multisystem autoimmune disease."1.51Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus. ( Bijl, M; Bultink, IEM; de Leeuw, K; Dolhain, RJEM; Fritsch-Stork, R; Groot, N; Kamphuis, S; Shaikhani, D; Teng, YKO; Zirkzee, E, 2019)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Trefond, L1
Drumez, E1
Andre, M1
Costedoat-Chalumeau, N1
Seror, R1
Devaux, M1
Dernis, E1
Dieudonné, Y1
El Mahou, S1
Lanteri, A1
Melki, I1
Queyrel, V1
Roumier, M1
Schmidt, J1
Barnetche, T1
Thomas, T1
Cacoub, P1
Belot, A1
Aumaitre, O1
Richez, C1
Hachulla, E1
Martí-Carvajal, A1
Ramon-Pardo, P1
Javelle, E1
Simon, F1
Aldighieri, S1
Horvath, H1
Rodriguez-Abreu, J1
Reveiz, L1
Groot, N1
Shaikhani, D1
Teng, YKO1
de Leeuw, K1
Bijl, M1
Dolhain, RJEM1
Zirkzee, E1
Fritsch-Stork, R1
Bultink, IEM1
Kamphuis, S1
Chopra, A1
Anuradha, V1
Lagoo-Joshi, V1
Kunjir, V1
Salvi, S1
Saluja, M1
BUTTERWORTH, RF1

Reviews

1 review available for hydroxychloroquine and Orthopedic Disorders

ArticleYear
Interventions for treating patients with chikungunya virus infection-related rheumatic and musculoskeletal disorders: A systematic review.
    PloS one, 2017, Volume: 12, Issue:6

    Topics: Antirheumatic Agents; Chikungunya Fever; Chikungunya virus; Chloroquine; Humans; Hydroxychloroquine;

2017

Other Studies

4 other studies available for hydroxychloroquine and Orthopedic Disorders

ArticleYear
Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases.
    Joint bone spine, 2021, Volume: 88, Issue:6

    Topics: Antirheumatic Agents; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Musculoskeletal Diseases;

2021
Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
    Arthritis & rheumatology (Hoboken, N.J.), 2019, Volume: 71, Issue:2

    Topics: Adolescent; Adult; Age of Onset; Aged; Antibodies, Antiphospholipid; Antirheumatic Agents; Child; Ch

2019
Chikungunya virus aches and pains: an emerging challenge.
    Arthritis and rheumatism, 2008, Volume: 58, Issue:9

    Topics: Alphavirus Infections; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Chikungunya vi

2008
The burning skin syndrome: treatment with hydroxychloroquine.
    The Medical journal of Australia, 1960, Sep-17, Volume: 47(2)

    Topics: Chloroquine; Dermatology; Humans; Hydroxychloroquine; Musculoskeletal Diseases; Pain; Paresthesia; S

1960